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Mercury is a ubiquitous environmental toxi-
cant (Goldman et al. 2001). It exists in three
forms, each of which possesses different
bioavailability and toxicity: the metallic ele-
ment, inorganic salts, and organic compounds
(methyl mercury, ethyl mercury, and phenyl
mercury) (Franzblau 1994). Although volca-
noes and other natural sources release some
elemental mercury to the environment, anthro-
pogenic emissions from coal-fired electric
power generation facilities, chloralkali produc-
tion, waste incineration, and other industrial
activities now account for approximately 70%
of the 5,500 metric tons of mercury that are
released into the earth’s atmosphere each year
[United Nations Environmental Programme
(UNEP) 2002]. Elemental mercury is readily
aerosolized because of its low boiling point, and
once airborne it can travel long distances to
eventually deposit into soil and water. In the
sediments of rivers, lakes, and the ocean, metal-
lic mercury is transformed within microorgan-
isms into methyl mercury (Guimaraes et al.
2000). This methyl mercury biomagniﬁes in
the marine food chain to reach very high con-
centrations in predatory fish such as sword-
fish, tuna, king mackerel, and shark (Dietz
et al. 2000; Gilmour and Riedel 2000;
Mason et al. 1995; Neumann and Ward
1999). Consumption of contaminated ﬁsh is
the major route of human exposure to methyl
mercury.
The toxicity of methyl mercury to the
developing brain was first recognized in the
1950s in Minamata, Japan, where consump-
tion of ﬁsh with high concentrations of methyl
mercury by pregnant women resulted in at
least 30 cases of cerebral palsy in children;
exposed women were affected minimally if at
all (Harada 1968). A similar episode followed
in 1972 in Iraq when the use of a methyl
mercury fungicide led to poisoning in thou-
sands of people (Bakir et al. 1973); again,
infants and children were most profoundly
affected (Amin-Zaki et al. 1974, 1979). The
vulnerability of the developing brain to
methyl mercury reflects the ability of lipo-
philic methyl mercury to cross the placenta
and concentrate in the central nervous system
(Campbell et al. 1992). Moreover, the
blood–brain barrier is not fully developed
until after the first year of life, and methyl
mercury can cross this incomplete barrier
(Rodier 1995).
Three recent, large-scale prospective epi-
demiologic studies have examined children
who experienced methyl mercury exposures
in utero at concentrations relevant to current
U.S. exposure levels. The ﬁrst of these studies,
a cohort in New Zealand, found a 3-point
decrement in the Wechsler Intelligence Scale-
Revised (WISC-R) full-scale IQ among
children born to women with maternal hair
mercury concentrations > 6 µg/g (Kjellstrom
et al. 1986, 1989). A second study in the
Seychelles Islands in the Indian Ocean found
only one adverse association with maternal
hair mercury concentration among 48 neuro-
developmental end points examined (pro-
longed time to complete a grooved pegboard
test with the nonpreferred hand) (Myers et al.
2003). However, the grooved pegboard test
was one of the few neurobehavioral instru-
ments in the Seychelles study not subject to
the vagaries of translation that can degrade
the validity of culture-bound tests of higher
cognitive function when they are applied in
developing nations (Landrigan and Goldman
2003). A third prospective study in the Faroe
Islands, a component of Denmark inhabited
by a Scandinavian population in the North
Atlantic, has followed a cohort of children
for 14 years and collected data on 17 neuro-
developmental end points, as well as on the
impact of methyl mercury on cardiovascular
function. The Faroes researchers found sig-
nificant dose-related, adverse associations
between prenatal mercury exposure and per-
formance on a wide range of memory, atten-
tion, language, and visual-spatial perception
tests (Grandjean et al. 1997). The signiﬁcance
of these associations remained evident when
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Methyl mercury is a developmental neurotoxicant. Exposure results principally from consumption
by pregnant women of seafood contaminated by mercury from anthropogenic (70%) and natural
(30%) sources. Throughout the 1990s, the U.S. Environmental Protection Agency (EPA) made
steady progress in reducing mercury emissions from anthropogenic sources, especially from power
plants, which account for 41% of anthropogenic emissions. However, the U.S. EPA recently pro-
posed to slow this progress, citing high costs of pollution abatement. To put into perspective the
costs of controlling emissions from American power plants, we have estimated the economic costs
of methyl mercury toxicity attributable to mercury from these plants. We used an environmentally
attributable fraction model and limited our analysis to the neurodevelopmental impacts—speciﬁ-
cally loss of intelligence. Using national blood mercury prevalence data from the Centers for
Disease Control and Prevention, we found that between 316,588 and 637,233 children each year
have cord blood mercury levels > 5.8 µg/L, a level associated with loss of IQ. The resulting loss of
intelligence causes diminished economic productivity that persists over the entire lifetime of these
children. This lost productivity is the major cost of methyl mercury toxicity, and it amounts to
$8.7 billion annually (range, $2.2–43.8 billion; all costs are in 2000 US$). Of this total, $1.3 bil-
lion (range, $0.1–6.5 billion) each year is attributable to mercury emissions from American power
plants. This signiﬁcant toll threatens the economic health and security of the United States and
should be considered in the debate on mercury pollution controls. Key words: children’s health,
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blood levels of polychlorinated biphenyls,
which are known developmental neuro-
toxicants (Jacobson and Jacobson 1996), were
included in the analysis (Budtz-Jorgensen
et al. 2002; Steuerwald et al. 2000). Methyl
mercury exposure was also associated with
decreased sympathetic- and parasympathetic-
mediated modulation of heart rate variability
(Grandjean et al. 2004) and with persistent
delays in peaks I–III brainstem evoked poten-
tials (Murata et al. 2004).
An assessment of these three prospective
studies by the National Academy of Sciences
(NAS) (National Research Council 2000)
concluded that there is strong evidence for the
fetal neurotoxicity of methyl mercury, even at
low concentrations of exposure. Moreover,
the NAS opined that the most credible of the
three prospective epidemiologic studies was
the Faroe Islands investigation. In recom-
mending a procedure for setting a reference
dose for a methyl mercury standard, the NAS
chose to use a linear model to represent the
relationship between mercury exposure and
neurodevelopmental outcomes, and based this
model on the Faroe Islands data. The NAS
found that the cord blood methyl mercury
concentration was the most sensitive bio-
marker of exposure in utero and correlated
best with neurobehavioral outcomes. The
NAS was not deterred by the apparently nega-
tive findings of the Seychelles Islands study,
which it noted was based on a smaller cohort
than the Faroe Islands investigation and had
only 50% statistical power to detect the effects
observed in the Faroes (National Research
Council 2000).
Since January 2003, the issue of early
life exposure to methyl mercury has become
the topic of intense debate after the U.S.
Environmental Protection Agency (EPA)
announced a proposal to reverse strict controls
on emissions of mercury from coal-ﬁred power
plants. This proposed “Clear Skies Act” would
slow recent progress in controlling mercury
emission rates from electric generation facilities
and would allow these releases to remain as
high as 26 tons/year through 2010 (U.S. EPA
2004a). By contrast, existing protections under
the Clean Air Act will limit mercury emissions
from coal-ﬁred power plants to 5 tons/year by
2008 (U.S. EPA 2004b). The U.S. EPA’s tech-
nical analyses in support of “Clear Skies” failed
to incorporate or quantify consideration of the
health impacts resulting from increased mer-
cury emissions (U.S. EPA 2004c). After legisla-
tive momentum for this proposal faded, the
U.S. EPA proposed an almost identical Utility
Mercury Reductions Rule, which again failed
to examine impacts on health. The U.S. EPA
issued a final rule on 15 March 2005 (U.S.
EPA 2005).
To assess the costs that may result from
exposure of the developing brain to methyl
mercury, we estimated the economic impact
of anthropogenic methyl mercury exposure in
the 2000 U.S. birth cohort. We calculated the
fraction of this cost that could be attributed to
mercury emitted by American electric power
generation facilities.
Materials and Methods
Environmentally attributable fraction model.
To assess the disease burden and the costs
due to methyl mercury exposure, we used an
environmentally attributable fraction (EAF)
model. The EAF approach was developed by
the Institute of Medicine (IOM) to assess the
“fractional contribution” of the environment
to causation of illness in the United States
(IOM 1981), and it has been used to assess
the costs of environmental and occupational
disease (Fahs et al. 1989; Leigh et al. 1997). It
was used recently to estimate the environmen-
tally attributable costs of lead poisoning,
asthma, pediatric cancer, and neurodevelop-
mental disabilities in American children
(Landrigan et al. 2002). The EAF is defined
by Smith et al. (1999) as “the percentage of a
particular disease category that would be
eliminated if environmental risk factors were
reduced to their lowest feasible concentra-
tions.” The EAF is a composite value and is
the product of the prevalence of a risk factor
multiplied by the relative risk of disease associ-
ated with that risk factor. Its calculation is
useful in developing strategies for resource
allocation and prioritization in public health.
The general model developed by the IOM and
used in the present analysis is the following:
Costs = disease rate × EAF × population size 
× cost per case
“Cost per case” refers to discounted life-
time expenditures attributable to a particular
disease, including direct costs of health care,
costs of rehabilitation, and lost productivity.
“Disease rate” and “population size” refer,
respectively, to the incidence or prevalence of
a disease and the size of the population at risk.
In applying the EAF model, we first
reviewed the adverse effects of methyl mercury
exposure. We then estimated the costs of those
effects and subsequently applied a further frac-
tion to parse out the cost of anthropogenic
methyl mercury exposure resulting from emis-
sions of American electrical generation facilities.
Toxic effects of methyl mercury exposure.
The NAS found neurodevelopmental effects in
the children of women who had consumed ﬁsh
and seafood during pregnancy to be the most
important and best-studied end point for
methyl mercury toxicity. Although the NAS
identiﬁed other potentially signiﬁcant toxicities
resulting from methyl mercury exposure, such
as nephrotoxicity and carcinogenicity, those
effects were less well characterized (National
Research Council 2000). We therefore limited
our analysis to the neurodevelopmental impact
of methyl mercury toxicity.
There is no evidence to date validating the
existence of a threshold blood mercury con-
centration below which adverse effects on
cognition are not seen. The U.S. EPA has,
however, set a benchmark dose level (BMDL)
for cord blood mercury dose concentration of
58 µg/L. This level that corresponds to the
lower limit of the 95% conﬁdence interval for
the concentration at which there is a doubling
in the Faroes study in the prevalence of test
scores (5–10%) in the clinically subnormal
range for the Boston Naming Test (Rice et al.
2003). It is important to note that this is not
a concentration below which no observed
adverse effects were found. The Faroes and
New Zealand cohorts both support the con-
clusion that developmental effects become
apparent at levels of approximately 1 ppm
mercury in hair, or 5.8 µg/L in cord blood
(Grandjean et al. 1997; Kjellstrom et al.
1986, 1989). The Faroes study also found
that effects on delayed brainstem auditory
responses occurred at much lower exposure
concentrations (Murata et al. 2004). In its
report, the NAS concluded that the likelihood
of subnormal scores on neurodevelopmental
tests after in utero exposure to methyl mer-
cury increased as cord blood concentrations
increased from levels as low as 5 µg/L to
the BMDL of 58 µg/L (National Research
Council 2000). In light of those ﬁndings, we
decided in this analysis to apply a no adverse
effect level of 5.8 µg/L, the lowest level at
which adverse neurodevelopmental effects
were demonstrated in the cohort studies.
Recent data suggest that the cord blood
mercury concentration may on average be 70%
higher than the maternal blood mercury con-
centration (Stern and Smith 2003), and a
recent analysis suggests that a modiﬁcation of
the U.S. EPA reference dose for methyl mer-
cury be made to reﬂect a cord blood:maternal
blood ratio that is > 1 (Stern 2005). If the
developmental effects of mercury exposure do,
in fact, begin at 5.8 µg/L in cord blood, as sug-
gested by the Faroes (Grandjean et al. 1997)
and New Zealand (Kjellstrom et al. 1986,
1989) data and by the NAS report (National
Research Council 2000), then effects would
occur in children born to women of child-
bearing age with blood mercury concentrations
≥ 3.41 (ratio, 5.8:1.7) µg/L. National popu-
lation data from the 1999–2000 National
Health and Nutrition Examination Survey
(NHANES) found that 15.7% of American
women of childbearing age have total blood
mercury concentrations ≥ 3.5 µg/L (Mahaffey
et al. 2004).
To compute IQ decrements in infants that
have resulted from these elevated maternal
mercury exposures, we used published data on
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with mercury concentrations ≥ 3.5, 4.84, 5.8,
7.13, and 15.0 µg/L. We assumed conserva-
tively that all mercury concentrations within
each of the segments of the distribution were
at the lower bound of the range. We assumed
that the probability of giving birth to a child
did not correlate with mercury level in a
woman of childbearing age. In our base case
analysis, we calculated economic costs assum-
ing that children born to women with mer-
cury concentrations 3.5–4.84 µg/L suffer no
loss in cognition, and that successive portions
of the birth cohort experience loss of cognition
associated with cord blood levels of 8.2, 9.9,
12.1, and 25.5 µg/L, respectively.
Recently, the Faroes researchers reviewed
their cohort data and found fetal blood mer-
cury concentrations to be only 30% higher
than maternal blood concentrations (Budtz-
Jorgensen et al. 2004). In light of these ﬁnd-
ings and to avoid overestimation of the
magnitude of impacts, we chose not to include
children born to mothers with blood mercury
concentrations between 3.5 and 4.84 µg/L in
our base case analysis.
To assess the impact on our ﬁndings of a
range of various possible ratios between mater-
nal and cord blood mercury concentrations,
we conducted a sensitivity analysis. In this
analysis, we set as a lower bound for our esti-
mate the costs to children with estimated cord
blood concentrations ≥ 5.8 µg/L (assuming a
cord:maternal blood ratio of 1) and assumed
no IQ impact < 4.84 µg/L (assuming a
cord:maternal blood ratio of 1.19). This esti-
mate assumed no loss of cognition to children
born to women with mercury concentration
< 5.8 µg/L and assumed that subsequent por-
tions of the birth cohort experienced cord
blood mercury concentrations of 5.8, 7.13,
and 15 µg/L, respectively. To estimate eco-
nomic costs in this scenario, we calculated no
costs for children with blood mercury con-
centrations < 4.84 µg/L. We calculated costs
resulting from an incremental increase in
blood mercury concentration from 4.84 to
5.8 µg/L in the percentage of the population
with blood mercury levels between 5.8 and
7.13 µg/L, and added those costs to the
costs resulting from increases from 4.84 to
7.13 µg/L and 4.84 to 15 µg/L in the percent-
ages of the population with concentrations
between 7.13 and 15 µg/L and > 15 µg/L,
respectively. The result of this calculation is
expressed in our analysis as a lower bound for
the true economic cost of methyl mercury
toxicity to the developing brain.
Impact of methyl mercury exposure on IQ.
The Faroes study found that a doubling of
mercury concentration was associated with
adverse impacts on neurodevelopmental tests
ranging from 5.69–15.93% of a standard devi-
ation (Grandjean et al. 1999). Assuming that
IQ is normally distributed with a standard
deviation of 15 points, a doubling of mercury
concentration would be associated with a
decrement ranging from 0.85 to 2.4 IQ points.
The Faroes researchers used a structural equa-
tion analysis to produce estimates of impact of
methyl mercury on verbal and motor function
at 7 years of age and found an association
between a doubling of blood mercury and loss
of 9.74% of a standard deviation on motor
function and of 10.45% of a standard devia-
tion on verbal function (Budtz-Jorgensen et al.
2002). This analysis suggests that a doubling in
mercury concentration produces a decrement
of approximately 10% of a standard deviation,
or 1.5 IQ points. In the New Zealand study
(Kjellstrom et al. 1986, 1989), the average
WISC-R full-scale IQ for the study population
(n = 237) was 93. In the group with maternal
hair mercury > 6 µg/g (~ 4-fold higher than in
the study population, n = 61), the average was
90 (Kjellstrom et al. 1989). This finding
further supports our use of a loss of 1.5 IQ
points for each doubling in our base case analy-
sis. Confounders such as polychlorinated
biphenyls did not cause signiﬁcant confound-
ing of the data in the Faroe Islands study
(Budtz-Jorgensen et al. 2002; Steuerwald et al.
2000). As a conservative measure, we nonethe-
less chose to set as outer bounds for the impact
on intelligence of methyl mercury exposure a
range of IQ decrements from 0.85 to 2.4 IQ
points per doubling, as described by the Faroes
researchers (Jorgensen et al. 2004). In applying
the EAF methodology, we assume that the
relationship between cord blood mercury and
IQ is relatively linear over the range of expo-
sures studied (> 5.8 µg/L).
In our sensitivity analysis, we used the
same linear dose–response model that was
selected by the National Research Council in
setting a reference dose for mercury exposure
(National Research Council 2000). The
Faroes researchers found that, for those chil-
dren whose mothers had hair mercury concen-
trations < 10 µg/g, a 1-µg/L increase of cord
blood mercury concentration was associated
with adverse impacts on neurodevelopmental
tests ranging from 3.95 to 8.33% of a stan-
dard deviation, or 0.59–1.24 IQ points (aver-
age = 0.93 IQ points) (Jorgensen et al. 2004).
We also varied the cord:maternal blood mer-
cury ratio from 1 to 1.7 in calculating IQ
impact from the linear model as part of our
sensitivity analysis. As an upper bound to our
cost estimate using the logarithmic model, we
calculated the economic cost assuming that
children born to women with mercury con-
centrations 3.5–4.84 µg/L suffer no loss in
cognition and that successive portions of the
birth cohort experience losses of cognition of
1.21, 1.84, 2.55, and 5.13 IQ points, respec-
tively. The lower-bound estimate assumed
that children born to women with mercury
concentrations 4.84–5.8 µg/L suffer no loss in
cognition and that successive portions of the
birth cohort experience losses of cognition of
0.22, 0.48, and 1.39 IQ points.
As an upper bound to our cost estimate
using the linear model, we calculated the
economic cost assuming that children born
to women with mercury concentrations
3.5–4.84 µg/L suffer no loss in cognition and
that successive portions of the birth cohort
experience losses of cognition of 3.01, 5.04,
7.84, and 24.43 IQ points, respectively. The
lower-bound estimate assumed that children
born to women with mercury concentrations
4.84–5.8 µg/L suffer no loss in cognition and
that successive portions of the birth cohort
experience losses of cognition of 0.56, 1.35,
and 5.99 IQ points.
Calculation of economic costs of IQ loss.
To estimate the costs associated with the
cognitive and behavioral consequences of
mercury exposure, we relied on an economic
forecasting model developed by Schwartz
et al. (1985), and we applied this model to
NHANES data on prevalence of mercury
exposure in women of childbearing age
(Schober et al. 2003; Schwartz et al. 1985). In
this model, lead concentrations are assumed
on the basis of work by Salkever (1995) to
produce a dose-related decrement in IQ score.
Those decrements in IQ are, in turn, associ-
ated with lower wages and diminished life-
time earning power. Salkever used three
regression techniques to derive direct and
indirect relationships among IQ, schooling,
probability of workforce participation, and
earnings. He estimated a percentage in lost
earnings per IQ point from the percent loss of
earnings for each microgram per deciliter
increase in blood lead level. Salkever found a
0.473 point decrement in lost lifetime earn-
ings for each microgram per deciliter increase
among men and a 0.806 point decrement for
each microgram per deciliter increase among
women (Salkever 1995). Using Schwartz’s
(1994) estimate that 0.245 IQ points are lost
for each microgram per deciliter increase in
blood lead, Salkever (1995) estimated a per-
centage loss in lifetime earnings per IQ point
among men (1.931%) and women (3.225%).
We assume that this relationship remains lin-
ear across the population range of IQ.
Assuming an annual growth in productiv-
ity of 1% and applying a 3% real discount
rate, the present value of lifetime expected
earnings is $1,032,002 for a boy born in
2000 and $763,468 for a girl born in the
same year (Max et al. 2002). The costs of
the diminution in this earning power were
calculated for the 2000 American birth
cohort, using available data on the number of
male and female births in 2000 [Centers
for Disease Control and Prevention (CDC)
2002a]. We diminished our cost estimate by
Children’s Health | Trasande et al.
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0.69%, the infant mortality rate in 2000, to
account for those children for whom methyl
mercury exposure is unlikely to result in
diminished economic productivity (CDC
2002b).
American sources of mercury emission.
Mercury emissions result from anthropogenic
as well as from natural sources, and we limited
our analysis to methyl mercury derived from
anthropogenic sources. The UNEP recently
estimated that anthropogenic uses account for
70% of the 5,500 tons of mercury released
into the earth’s atmosphere worldwide (UNEP
2002). Therefore, to limit our analysis to
anthropogenic mercury, we applied a 70%
factor to convert the cost of lost economic pro-
ductivity resulting from methyl mercury expo-
sure to the cost attributable to anthropogenic
methyl mercury exposure.
We next parsed out the proportion of
anthropogenic methyl mercury in fish that
arises from American sources and then isolated
the subset of that proportion that is emitted
by coal-fired electrical generating plants. In
1995, the most recent year for which federal
data on the relative deposition of mercury
from American and other global sources are
available, 158 tons of mercury were emitted to
the atmosphere by American anthropogenic
sources. Fifty-two (33%) of those 158 tons
were deposited in the lower 48 states, whereas
the remaining two-thirds were added to the
global reservoir (U.S. EPA 2004d). Also in
1995, an additional 35 tons of mercury from
the global reservoir were deposited in the
United States. Therefore, a total of 87 total
tons of mercury were deposited in the United
States in that year, of which 60% (52 of 87)
were attributable to American anthropogenic
sources (U.S. EPA 1996, 1997). This mercury
would have been available to bioaccumulate in
the marine and aquatic food chains and to
enter American freshwater and saltwater ﬁsh.
Further complicating our calculations is
the fact that not all of the ﬁsh sold in America
is from American sources. Of the 10.4 billion
pounds of edible ﬁsh supplied in the United
States in 2002, 4.4 billion (42%) are imported
from sources outside of the United States
(National Marine Fisheries Service 2002).
Because U.S. emissions account for 3% of
global emissions (UNEP 2002; U.S. EPA
1996), we calculate that the mercury content
of imported fish is 2% of American anthro-
pogenic origin: 158 tons of American emis-
sions – 52 tons of American mercury deposited
on American soil = 106 tons of American
mercury available to contaminate imported
fish; 5,500 tons emitted globally – 87 tons
deposited on American soil = 5,413 tons of
mercury from all sources to contaminate
imported ﬁsh; 106 tons of mercury available/
5,413 tons of mercury from all sources = 0.02,
or 2% of mercury in imported fish of
American origin. In the remaining 58% of ﬁsh
consumed in the United States, we assume that
60% of the mercury content comes from
American anthropogenic sources (U.S. EPA
1996, 1997). We therefore applied a 36% fac-
tor (the weighted average of American sources
of mercury content in fish, or 0.6 × 0.58 +
0.02 × 0.42) to specify the economic costs of
anthropogenic methyl mercury exposure
attributable to American sources.
Modeling supported by the Electric Power
Resource Institute (EPRI) estimates that 70%
of the mercury deposited in the United States
comes from foreign sources (Seigneur et al.
2004). This EPRI analysis also ﬁnds that U.S.
sources are responsible for > 60% of mercury
deposition in the Boston–Washington, D.C.
corridor. In one of the model’s selected recep-
tor areas—Pines Lake, New Jersey—80% of
the deposition originated from U.S. sources,
showing that regional deposition can be higher
than the 60% number we use in this analysis
(Seigneur et al. 2004). In our sensitivity analy-
sis, we varied the factor used to convert the
economic cost of anthropogenic methyl mer-
cury exposure to the economic cost attributable
to American sources from 18% (0.3 × 0.58 +
0.02 × 0.42, using EPRI’s modeling) to 36%
(using federal data on mercury deposition)
(Seigneur et al. 2004).
In 1999, the most recent year for which
data on American mercury emissions are avail-
able, 48 (41%) of the 117 tons of mercury
emissions from anthropogenic sources in the
United States were emitted by electric power
generation facilities (U.S. EPA 2003a). To cal-
culate the economic cost of methyl mercury
exposure attributable to these facilities, we
applied an additional fraction of 41% in our
analysis.
Results
Base-case analysis. Each year in the United
States, between 316,588 (7.8% of the annual
birth cohort) and 637,233 babies are born
with cord blood mercury levels > 5.8 µg/L.
The lower-bound estimate of 316,588 babies
is based on the very conservative assumption
that maternal and cord blood mercury con-
centrations are equal. But if the cord blood
mercury concentration is on average 70%
higher than the maternal blood mercury con-
centration, as suggested by recent research
(Stern and Smith 2003), 637,233 babies, or
15.7% of the birth cohort, experience cord
blood mercury levels > 5.8 µg/L. Fetal blood
mercury levels > 5.8 µg/L are associated with
small but significant loss of IQ. This decre-
ment in IQ appears to be permanent and irre-
versible, and it adversely affects a significant
portion of the annual birth cohort’s economic
productivity over a lifetime.
Using our base-case assumptions (impact
for women with total mercury > 4.84 µg/L,
cord:maternal mercury ratio = 1.7, IQ impact
= 1.5 points per doubling), we calculated costs
for the 405,881 children who suffer IQ decre-
ments resulting from fetal methyl mercury
exposure. Under these assumptions, 89,293
children suffered a 0.76 decrement in IQ and
another 113,647 experienced a 1.15 IQ point
decrement. The 5% most highly exposed
children in the 2000 birth cohort suffered
subclinical losses in IQ in our model ranging
from 1.60 to 3.21 points. Although this
diminution in intelligence is small in com-
parison with the loss of cognition that can
result from other genetic and environmental
processes, the loss resulting from methyl mer-
cury exposure produces a signiﬁcant reduction
in economic productivity over a lifetime. We
estimate the aggregate cost of the loss in IQ
that results from exposure of American chil-
dren to methyl mercury of anthropogenic ori-
gin to be $8.7 billion (all costs in 2000 US$)
annually (Table 1).
Sensitivity analysis. We estimate that the
cost of anthropogenic methyl mercury expo-
sure ranges from $2.2 billion (impact only for
the 316,588 children born to women with
total mercury > 5.8 µg/L, IQ impact = 0.85
points per doubling) to $13.9 billion (impact
for the 405,881 women with total mercury
> 4.84 µg/L, IQ impact = 2.4 points per dou-
bling). Using the linear dose–response model
that was selected by the National Research
Council in recommending a reference dose
for mercury exposure (a model that predicts
an average loss of 0.93 IQ points per 1-µg/L
increase in mercury concentration) (Jorgensen
et al. 2004; National Research Council 2000),
we ﬁnd that the environmentally attributable
cost of methyl mercury exposure is $32.9 bil-
lion, assuming a cord:maternal blood mercury
ratio of 1.7. Employing a linear model and
assuming that the true loss in IQ resulting
from a 1-µg/L increase in blood mercury
ranges from 0.59 to 1.24 points, we ﬁnd that
the outer bounds of our estimate range from
$7.0 billion (impact only for women with total
mercury > 5.8 µg/L, IQ impact = 0.59 points
per µg/L increase, cord:maternal mercury
ratio = 1) to $43.8 billion (impact for women
with total mercury > 4.84 µg/L, IQ impact =
1.24 points for each microgram per deciliter
increase, cord:maternal mercury ratio = 1.7)
(Table 2).
Sources of costs. After applying the 36%
fraction to restrict our analysis to American
anthropogenic sources, we estimate that the
attributable cost of methyl mercury exposure
to the developing fetus from American
anthropogenic sources is $3.1 billion annu-
ally, using the logarithmic model developed
by the Faroes researchers (Grandjean et al.
1999; Jorgensen et al. 2004) and assuming a
1.5-point IQ impact for each doubling of
methyl mercury exposure (Budtz-Jorgensen
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we also varied the attributable fraction for
American sources from 18% (industry data
sources) to 36% (federal data sources) (Seigneur
et al. 2004; U.S. EPA 1996, 1997), suggests
that the true cost of methyl mercury exposure
from American emissions ranges from $0.4 to
$15.8 billion annually.
To focus specifically on the costs of fetal
exposure to mercury released by American coal-
ﬁred power plants, we examined the impact of
the 41% of U.S. anthropogenic emissions of
mercury attributable to these facilities. We
estimate that the attributable cost of methyl
mercury exposure from American electric gen-
eration facilities to the developing fetus is
$1.3 billion. Applying our sensitivity analysis in
this model, we ﬁnd that the true cost of methyl
mercury exposure from electric generation facil-
ities to the American birth cohort ranges from
$0.1 to $6.5 billion/year (Figure 1). Again, the
major source of these costs is loss of earnings
over a lifetime.
Discussion
The major ﬁndings in this analysis are a) that
exposure to methyl mercury emitted to the
atmosphere by American electric generation
facilities causes lifelong loss of intelligence in
hundreds of thousands of American babies
born each year and b) that this loss of intelli-
gence exacts a significant economic cost to
American society, a cost that amounts to at
least hundreds of millions of dollars each year.
Moreover, these costs will recur each year with
each new birth cohort as long as mercury emis-
sions are not controlled. By contrast, the cost
of installing stack ﬁlters to control atmospheric
mercury emissions is a one-time expense. The
high costs of in utero exposure to methyl mer-
cury are due principally to the lifelong conse-
quences of irreversible injury to the developing
brain. Similar lifelong neurobehavioral conse-
quences have been observed after exposure of
the developing brain to other environmental
toxicants, including lead (Baghurst et al. 1987;
Bellinger 2004; Dietrich et al. 1987; Opler
et al. 2004; Wasserman et al. 2000), poly-
chlorinated biphenyls (Jacobson and Jacobson
1996), and ethanol (Lupton et al. 2004).
Because the literature has presented a range
of possible consequences for methyl mercury
toxicity, we have provided a range of possible
public health and economic consequences.
This range is meant to inform the choices that
environmental and public health ofﬁcials make
in protecting vulnerable populations from
methyl mercury exposure. Our range for the
true economic costs of methyl mercury toxicity
to the developing brain omits the cost of expo-
sures to the 231,352 children born to women
in 2000 with blood mercury concentrations
between 3.5 and 4.84 µg/L. If the true cord
blood ratio is 1.7 times the maternal blood
concentration, as described in the most recent
and extensive meta-analysis on the matter
(Stern and Smith 2003), these children are also
born with cord blood mercury concentrations
above the 5.8 µg/L concentration at which
adverse neurodevelopmental impact has been
found. We chose not to include them in our
analysis because other studies have found lower
ratios and because we restricted ourselves in
this analysis to the use of available, published
prevalence data of maternal blood mercury
concentrations. In our sensitivity analysis, we
also selected low cord:maternal blood ratios so
as to describe most accurately the range of val-
ues for the true cost of methyl mercury expo-
sure to the developing fetus.
Our analysis also omits the cost of the
cardiovascular impacts of mercury exposure
(Grandjean et al. 2004) or the costs of mer-
cury exposure to children in the ﬁrst 2 years of
postnatal life, when myelination is still contin-
uing and the blood–brain barrier remains vul-
nerable to penetration by methyl mercury
(Rodier 1995). We chose not to include these
aspects of methyl mercury toxicity in our
range of estimates at this time because there
do not exist sufﬁcient quantitative data to per-
mit construction of a reliable model.
A limitation on our analysis is that it did
not consider other societal costs beyond
decreased lifetime earnings that may result
from exposure of the developing brain to
methyl mercury. For example, if the value of
a child’s social productivity is approximately
$4–9 million, as suggested by studies of
willingness-to-pay (WTP) estimates of a life
(Viscusi and Aldy 2004), then by the WTP
methodology the true cost of methyl mercury
toxicity may be much higher than our esti-
mate. We also chose not to include other
noncognitive impacts. Lead, for example, has
been associated with criminality and antisocial
behavior (Dietrich et al. 2001; Needleman
et al. 1996, 2002; Nevin 2000; Stretesky and
Lynch 2001). However, because these behav-
iors have not been described as yet for methyl
mercury, we chose not to include such costs in
our estimate.
Some will argue that our range of costs fails
to incorporate the role of confounding factors
in quantifying the economic consequences of
methyl mercury exposure. It is true that efforts
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Table 1. Cost of anthropogenic mercury (Hg) exposure using a logarithmic model.
Segment of population (percentile)
Variable 90–92.1 Hg 92.2–94.9 Hg 95–99.3 Hg ≥ 99.4 Hg
Range of maternal total Hg concentration 4.84–5.8 µg/L 5.8–7.13 µg/L 7.13–15.0 µg/L > 15.0 µg/L
Assumed maternal total Hg concentration 4.84 5.8 7.13 15
No effect concentration (maternal total Hg) 3.41 3.41 3.41 3.41
IQ points lost at assumed concentration 0.76 1.15 1.60 3.21
Loss of 1 IQ points = decrease in lifetime earnings
For boys, lifetime earnings (1.931% decrease) $1,032,002
For girls, lifetime earnings (3.225% decrease) $763,468
No. of boys in birth cohort affected 45,693 58,155 91,387 12,462
No. of girls in birth cohort affected 43,601 55,492 87,201 11,891
Lost income $1.1 billion $2.0 billion $4.4 billion $1.2 billion
Total cost = $8.7 billion in each year’s birth cohort
Assumptions: EAF = 70%, main consequence = loss of IQ over lifetime.
Table 2. Sensitivity analysis: cost of anthropogenic methyl mercury exposure.
Variable Base-case cost estimate (range)a
Children born to women with Hg > 4.84 µg/L, effect > 3.5 µg/L
Logarithmic model $8.7 billion ($4.9–13.9 billion)
Linear model, cord:maternal Hg ratio = 1.7 $32.9 billion ($20.9–43.8 billion)
Linear model, cord:maternal Hg ratio = 1 $19.3 billion ($12.3–25.8 billion)
Children born to women with > 5.8 µg/L, effect > 4.84 µg/L
Logarithmic model $3.9 billion ($2.2–6.3 billion)
Linear model, cord:maternal Hg ratio = 1.7 $18.7 billion ($11.9–24.9 billion)
Linear model, cord:maternal Hg ratio = 1 $11.0 billion ($7.0–14.6 billion)
Range of estimates
Logarithmic model $2.2–13.9 billion
Linear model $7.0–43.8 billion
Assumptions: EAF = 70%, main consequence = loss of IQ over lifetime.
aBased on range of possible IQ decrement:increase cord blood mercury.
Figure 1. Portions of cost of methyl mercury expo-
sure attributed to sources. Assumptions: 18–36%
attributable to American sources; 41% of American
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to delineate the potential synergistic role of
methyl mercury and other chemicals in medi-
ating neurocognitive and other effects are
bedeviled by lack of knowledge about possible
interactions and synergies among chemicals or
between chemicals and other environmental
hazards, even though the environment of a
child includes mixtures of chemical and bio-
logic toxicants. Only a study of the magnitude
of the National Children’s Study will facilitate
simultaneous examination of the effects of
multiple chemical exposures, of interactions
among them, and of interactions among bio-
logic, chemical, behavioral, and social factors
(Trasande and Landrigan 2004). However,
we note that loss of cognition resulting from
methyl mercury exposure in the Faroe Islands
study remained evident when blood levels of
polychlorinated biphenyls, which are known
fetal neurotoxicants (Jacobson and Jacobson
1996), were included in the analysis (Budtz-
Jorgensen et al. 2002; Steuerwald et al. 2000).
We note the U.S. EPA’s recent success in
minimizing mercury emissions from medical
waste (U.S. EPA 2004e) and municipal incin-
erators (U.S. EPA 2004f, 2004g), actions that
resulted in a decrease in total mercury emis-
sions by at least 80 tons per year from 1990 to
1999 (U.S. EPA 2003b). Although data are
not available on blood mercury concentrations
over the past decade that followed from those
actions, the impact of these reductions is likely
to have been substantial.
Some commentators have used data from
the Seychelles study to argue that methyl mer-
cury is not toxic to the fetus at low concentra-
tions and to suggest that fear of mercury
exposure is needlessly preventing women from
ingesting ﬁsh and thus denying them access to
beneficial long-chain polyunsaturated fatty
acids (LCPUFAs), especially docosahexaenoic
acid (DHA). We do not dispute that DHA
and other LCPUFAs are important for opti-
mal development of the fetal visual and ner-
vous systems (Innis 1991). The human fetus
has a limited ability to synthesize DHA’s precur-
sor, α-linolenic acid, and therefore it must be
largely supplied from maternal sources (Carnielli
et al. 1996; Larque et al. 2002; Szitanyi et al.
1999). We also note a report that associated an
average monthly decline in ﬁsh consumption of
1.4 servings among Massachusetts women with
a U.S. Food and Drug Administration advisory
on the health risks of mercury (Oken et al.
2003). Nonetheless, the American Heart
Association, a strong advocate for the cardio-
protective effects of LCPUFAs, recommends
that children and pregnant and lactating
women avoid potentially contaminated fish
(Kris-Etherton et al. 2002). Fish advisories
should not recommend that consumers abstain
from fish, but they should assist in choosing
the best kinds of ﬁsh to eat. Lists of ﬁsh that
are safe and unsafe from the perspective of
mercury exposure have been published and
made widely available to consumers (U.S. EPA
2004h).
Early reports of disease and dysfunction of
environmental origin in children have on
repeated occasions failed to produce proactive
response to protect children. The long history
of lead use in the United States provides a
chilling reminder of the consequences of failure
to act on early evidence of harm. It is impor-
tant that we not repeat this sequence with mer-
cury. Within the last century, as a result of
increased industrial activity, mercury emissions
worldwide have increased 2- to 5-fold, and
anthropogenic emissions now surpass emis-
sions from natural sources (Nriagu 1989).
The data from this analysis reinforce the
results of recent epidemiologic studies and
indicate an urgent need on economic grounds
for regulatory intervention at the federal level
to minimize mercury emissions. Our analysis
captures the cost of methyl mercury exposure
for only 1 year’s birth cohort, but the cost of
mercury exposure will continue to accrue in
each succeeding year if power plants fail to
install flue gas filters (U.S. Department of
Energy 2004) or to implement other tech-
nologies to reduce mercury emissions. The
cost savings from reducing mercury exposure
now will provide savings in improved pro-
ductivity and enhanced national security for
generations to come.
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